Vania Bernardes‐Génisson

760 total citations
35 papers, 594 citations indexed

About

Vania Bernardes‐Génisson is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Vania Bernardes‐Génisson has authored 35 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 21 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Vania Bernardes‐Génisson's work include Cancer therapeutics and mechanisms (9 papers), Phenothiazines and Benzothiazines Synthesis and Activities (8 papers) and Tuberculosis Research and Epidemiology (7 papers). Vania Bernardes‐Génisson is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Phenothiazines and Benzothiazines Synthesis and Activities (8 papers) and Tuberculosis Research and Epidemiology (7 papers). Vania Bernardes‐Génisson collaborates with scholars based in France, Brazil and Italy. Vania Bernardes‐Génisson's co-authors include Geneviève Pratviel, Jean Bernadou, Jean‐Luc Stigliani, Céline Deraeve, Christian Lherbet, Laurent Maveyraud, Eduardo Henrique Silva Sousa, Luiz Gonzaga de França Lopes, Antoni Riéra and Andrew E. Greene and has published in prestigious journals such as Coordination Chemistry Reviews, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Vania Bernardes‐Génisson

34 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vania Bernardes‐Génisson France 15 292 242 147 78 51 35 594
Esra Tatar Türkiye 14 576 2.0× 161 0.7× 82 0.6× 62 0.8× 31 0.6× 37 820
Tanushree Ratan Bal India 10 419 1.4× 246 1.0× 114 0.8× 33 0.4× 51 1.0× 14 649
José Luís Lavandera Spain 14 186 0.6× 237 1.0× 79 0.5× 58 0.7× 50 1.0× 23 524
Yun Chai China 19 447 1.5× 586 2.4× 154 1.0× 30 0.4× 70 1.4× 37 870
Srinivasulu Cherukupalli China 18 577 2.0× 355 1.5× 228 1.6× 129 1.7× 148 2.9× 33 1.1k
Marshall Morningstar United States 11 519 1.8× 606 2.5× 89 0.6× 27 0.3× 42 0.8× 18 1.1k
Camilo Henrique da Silva Lima Brazil 13 325 1.1× 173 0.7× 77 0.5× 89 1.1× 74 1.5× 62 557
Mónica Cacho Spain 16 535 1.8× 643 2.7× 124 0.8× 31 0.4× 61 1.2× 23 1.0k
Vinita Chaturvedi India 15 766 2.6× 248 1.0× 110 0.7× 24 0.3× 45 0.9× 26 931
Yucheng Wang China 13 158 0.5× 121 0.5× 104 0.7× 33 0.4× 38 0.7× 47 481

Countries citing papers authored by Vania Bernardes‐Génisson

Since Specialization
Citations

This map shows the geographic impact of Vania Bernardes‐Génisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vania Bernardes‐Génisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vania Bernardes‐Génisson more than expected).

Fields of papers citing papers by Vania Bernardes‐Génisson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vania Bernardes‐Génisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vania Bernardes‐Génisson. The network helps show where Vania Bernardes‐Génisson may publish in the future.

Co-authorship network of co-authors of Vania Bernardes‐Génisson

This figure shows the co-authorship network connecting the top 25 collaborators of Vania Bernardes‐Génisson. A scholar is included among the top collaborators of Vania Bernardes‐Génisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vania Bernardes‐Génisson. Vania Bernardes‐Génisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caminade, Anne‐Marie, Vania Bernardes‐Génisson, Aurélien Hameau, et al.. (2025). Dendritic metallodrugs: An overview of their anticancer properties. Coordination Chemistry Reviews. 535. 216606–216606. 3 indexed citations
2.
Laurent, Régis, Valérie Maraval, Vania Bernardes‐Génisson, & Anne‐Marie Caminade. (2024). Dendritic Pyridine–Imine Copper Complexes as Metallo-Drugs. Molecules. 29(8). 1800–1800. 6 indexed citations
3.
Bouvet, J P, Valérie Maraval, Stéphanie Ballereau, Vania Bernardes‐Génisson, & Yves Génisson. (2024). Natural and Bioinspired Lipidic Alkynylcarbinols as Leishmanicidal, Antiplasmodial, Trypanocidal, Fungicidal, Antibacterial, and Antimycobacterial Agents. Journal of Natural Products. 87(10). 2550–2566. 2 indexed citations
4.
Cavalcante, Antônio Luthierre Gama, Pierre Basílio Almeida Fechine, Jeferson Yves Nunes Holanda Alexandre, et al.. (2022). Chemical modification of clay nanocomposites for the improvement of the catalytic properties of Lipase A from Candida antarctica. Process Biochemistry. 120. 1–14. 36 indexed citations
5.
Ridnour, Lisa A., Nilberto Robson Falcão do Nascimento, David A. Wink, et al.. (2020). A divergent mode of activation of a nitrosyl iron complex with unusual antiangiogenic activity. Journal of Inorganic Biochemistry. 210. 111133–111133. 7 indexed citations
6.
Paulo, Tércio de F., Alix Sournia‐Saquet, Bruno Lopes Abbadi, et al.. (2020). Pentacyanoferrate(II) complex of pyridine-4- and pyrazine-2-hydroxamic acid as source of HNO: investigation of anti-tubercular and vasodilation activities. JBIC Journal of Biological Inorganic Chemistry. 25(6). 887–901. 10 indexed citations
7.
Stigliani, Jean‐Luc & Vania Bernardes‐Génisson. (2019). New insights into the chemical behavior of S-oxide derivatives of thiocarbonyl-containing antitubercular drugs and the influence on their mechanisms of action and toxicity. Annales Pharmaceutiques Françaises. 77(2). 126–135. 5 indexed citations
8.
Maveyraud, Laurent, et al.. (2018). An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors. European Journal of Medicinal Chemistry. 146. 318–343. 47 indexed citations
9.
Deraeve, Céline, Alix Sournia‐Saquet, Lionel Rechignat, et al.. (2017). Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy. Journal of Inorganic Biochemistry. 179. 71–81. 17 indexed citations
10.
Stigliani, Jean‐Luc, Maria Rosalia Pasca, Giorgia Mori, et al.. (2016). Evaluation of the inhibitory activity of (aza)isoindolinone‐type compounds: toward in vitro InhA action, Mycobacterium tuberculosis growth and mycolic acid biosynthesis. Chemical Biology & Drug Design. 88(5). 740–755. 2 indexed citations
11.
Deraeve, Céline, Alix Sournia‐Saquet, Jean‐Luc Stigliani, et al.. (2016). Synthesis, oxidation potential and anti–mycobacterial activity of isoniazid and analogues: insights into the molecular isoniazid activation mechanism. ChemistrySelect. 1(2). 172–179. 17 indexed citations
12.
Mori, Giorgia, Christophe Menendez, Frédéric Rodriguez, et al.. (2015). Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth. European Journal of Medicinal Chemistry. 101. 218–235. 47 indexed citations
13.
Mourey, Lionel, Christian Lherbet, Sylviane Julien, et al.. (2015). Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach. Journal of Structural Biology. 190(3). 328–337. 39 indexed citations
14.
Bernardes‐Génisson, Vania, et al.. (2013). Isoniazid: an Update on the Multiple Mechanisms for a Singular Action. Current Medicinal Chemistry. 20(35). 4370–4385. 35 indexed citations
15.
Delaine, Tamara, Vania Bernardes‐Génisson, Annaı̈k Quémard, et al.. (2012). Preliminary Investigations of the Effect of Lipophilic Analogues of the Active Metabolite of Isoniazid Toward Bacterial and Plasmodial Strains. Chemical Biology & Drug Design. 79(6). 1001–1006. 3 indexed citations
16.
Stigliani, Jean‐Luc, Vania Bernardes‐Génisson, Jean Bernadou, & Geneviève Pratviel. (2012). Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations. Organic & Biomolecular Chemistry. 10(31). 6341–6341. 56 indexed citations
17.
Deraeve, Céline, Patricia Constant, Annaı̈k Quémard, et al.. (2011). Chemical synthesis, biological evaluation and structure–activity relationship analysis of azaisoindolinones, a novel class of direct enoyl-ACP reductase inhibitors as potential antimycobacterial agents. Bioorganic & Medicinal Chemistry. 19(21). 6225–6232. 13 indexed citations
18.
Bernardes‐Génisson, Vania, et al.. (2004). 2-Substituted-3H-indol-3-one-1-oxides: Preparation and Radical Trapping Properties. Free Radical Research. 38(5). 459–471. 9 indexed citations
19.
Bernardes‐Génisson, Vania, et al.. (2003). Access to Unsymmetrical 1,2-Diketone Intermediates via Benzeneseleninic Anhydride-Promoted Oxidation: Application to Indolone-N-Oxide Synthesis. Journal of Chemical Research. 2003(8). 507–508. 4 indexed citations
20.
Verdaguer, Xavier, Jordi Vázquez, Vania Bernardes‐Génisson, et al.. (1998). Camphor-Derived, Chelating Auxiliaries for the Highly Diastereoselective Intermolecular Pauson−Khand Reaction:  Experimental and Computational Studies. The Journal of Organic Chemistry. 63(20). 7037–7052. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026